BLCO MEXC RealStocks
Own real BLCO shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 13:04:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Bausch + Lomb Corporation (BLCO) operates in the OPHTHALMIC GOODS sector and is listed on NYSE. The stock is currently priced at $21.32, with a market capitalization of $7.64B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $14.44 to $21.40. This page covers its latest market performance, valuation, price trends and company information.
$7.64B | |
$21.33 | |
$21.34 | |
$21.32 | |
$21.32 | |
1.43K | |
636.63K | |
-- | |
$21.40 | |
$14.44 | |
-- | |
-- |
Bausch + Lomb Corporation (BLCO) is trading at $21.32 in pre-market trading as of 2026-11-12 12:55:00, unchanged from the previous close of $21.32
Pre-market trading shows how investors are pricing BLCO before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.
Over the past seven days, Bausch + Lomb Corporation (BLCO) moved from $20.03 to $21.32, representing a gain of 6.44% ($1.29).
The stock traded between $19.52 and $21.40 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 852.70 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 98.9%
BLCO is currently trading at $21.32, placing it 98.9% of the way from its 52-week low of $14.44 to its 52-week high of $21.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes brands like Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, and surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xiidra and Miebo that treat various eye complications.
| Industry | OPHTHALMIC GOODS |
| Employees | 13,000 |
| Exchange | NYSE |
| Company Website |
View the latest dividend and stock split events for Bausch + Lomb Corporation.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Bausch + Lomb Corporation (BLCO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to BLCO, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between BLCO shares and USD.
BLCO Shares to USD
1.00 BLCO shares = 21.32 USD
Calculations are estimates based on the latest available price and are for reference only.